(Q39836406)

15 September 2017

1 reference

title

The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy (English)

1 reference

15 September 2017

1 reference

1 reference

Djurup R

1

1 reference

15 September 2017

publication date

1 October 1985

1 reference

15 September 2017

1 reference

15 September 2017

volume

40

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

469-486

1 reference

The development of negative skin tests in children treated with venom immunotherapy.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

ELISA methodology for polysaccharide antigens: Protein coupling of polysaccharides for adsorption to plastic tubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Immunotherapy: Mechanisms of action suggested by measurements of immunologic and cellular parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Mechanisms of Reaginic Hypersensitivity and IgE Antibody Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Particle counting immunoassay of immunoglobulin E antibodies after their elution from allergosorbents by pepsin: an alternative to the radioallergosorbent test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

An overview of immunotherapy: Implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Trials of alum-precipitated pollen extracts in the treatment of hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Clinical efficacy of allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

The prognostic significance of specific IgG antibodies in insect sting allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Immunological studies on bee-keepers: specific IgG and subclass typing IgG against bee venom and bee venom components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Role of antibody classes in the regulatory facilitation reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00253.X

10.1111/J.1398-9995.1985.TB00253.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference